Liver cancer cells: Targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2767-2778

  Liao, Yu Te ^a   Liu, Chia Hung ^b   Yu, Jiashing ^a   Wu, Kevin C W ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Alginate; Atomization; Mesoporous silica nanoparticles; Sustained release; Targeting therapy

Indexed keywords

ALGINIC ACID; ARGINYLGLYCYLASPARTIC ACID; DOXORUBICIN; DRUG CARRIER; MICROSPHERE; NANOPARTICLE; RHODAMINE 6G; SILICON DIOXIDE; ARGINYL-GLYCYL-ASPARTIC ACID; DELAYED RELEASE FORMULATION; GLUCURONIC ACID; HEXURONIC ACID; NANOCAPSULE; OLIGOPEPTIDE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG TARGETING; DRUG UPTAKE; ENDOCYTOSIS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MOLECULARLY TARGETED THERAPY; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; PATHOLOGY; POROSITY; PROCEDURES; TREATMENT OUTCOME;

ALGINATES; ANIMALS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOXORUBICIN; GLUCURONIC ACID; HEP G2 CELLS; HEXURONIC ACIDS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MOLECULAR TARGETED THERAPY; NANOCAPSULES; OLIGOPEPTIDES; POROSITY; SILICON DIOXIDE; TREATMENT OUTCOME;

EID: 84901990086     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S60171     Document Type: Article

References (52)

1. Siegel R, DeSantis C, Virgo K, etal. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-241.
2. Marra M, Sordelli IM, Lombardi A, etal. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med. 2011;9:171.
3. Caraglia M, Giuberti G, Marra M, etal. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis. 2011;2:e150.
4. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999;39: 361-398.
5. Brito AF, Abrantes AM, Pinto-Costa C, etal. Hepatocellular carcinoma and chemotherapy: the role of p53. Chemotherapy. 2012;58(5): 381-386.
6. Tapiero H, Mishal Z, Wioland M, Silber A, Fourcade A, Zwingelstein G. Changes in biophysical parameters and in phospholipid composition associated with resistance to doxorubicin. Anticancer Res. 1986;6(4): 649-652.
7. Kellen JA. The reversal of multidrug resistance in cancer (review). Anticancer Res. 1993;13(4):959-961.
8. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631-651.
9. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278-1288.
10. Ariga K, Lvov YM, Kawakami K, Ji Q, Hill JP. Layer-by-layer self-assembled shells for drug delivery. Adv Drug Deliv Rev. 2011;63(9): 762-771.
11. Kawakami K, Ebara M, Izawa H, Sanchez-Ballester NM, Hill JP, Ariga K. Supramolecular approaches for drug development. Curr Med Chem. 2012;19(15):2388-2398.
12. Lian H-Y, Liang Y-H, Yamauchi Y, Wu KCW. A hierarchical study on load/release kinetics of guest molecules into/from mesoporous silica thin films. J Phys Chem C. 2011;115(4):6581-6590.
13. Torelli-Souza RR, Cavalcante Bastos LA, Nunes HGL, Camara CA, Amorim RVS. Sustained release of an antitumoral drug from alginate-chitosan hydrogel beads and its potential use as colonic drug delivery, J Appl Polym Sci. 2012;126:E409-E417.
14. Waki K, Anno K, Ono T, Ide T, Chayama K, Tahara H. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development. Cancer Sci. 2010;101(7):1678-1685.
15. Dibb M, Ang YS. Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatment. World J Gastroenterol. 2011;17(16): 2063-2069.
16. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615-627.
17. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J. 2004;377(Pt 1):159-169.
18. Fadeel B, Garcia-Bennett AE. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev. 2010;62(3):362-374.
19. Wu KC-W, Jiang X, Yamauchi Y. New trend on mesoporous films: precise controls of one-dimensional (1D) mesochannels toward innovative applications. J Mater Chem. 2011;21:8934-8939.
20. Wu KC-W, Yamauchi Y. Controlling physical features of mesoporous silica nanoparticles (MSNs) for emerging applications. J Mater Chem. 2012;22:1251-1256.
21. Vivero-Escoto JL, Chiang Y-D, Wu KC-W, Yamauchi Y. Recent progress in mesoporous titania materials: adjusting morphology for innovative applications. Sci Technol Adv Mater. 2012;13:013003.
22. Ariga K, Vinu A, Yamauchi Y, Ji Q, Hill JP. Nanoarchitectonics for mesoporous materials. Bull Chem Soc Jpn. 2012;85:1-32.
23. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6(18):1952-1967.
24. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release. 2006;114(1):1-14.
25. Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm. 2002;28(6):621-630.
26. Rajesh P, Khuller G. Alginate as a drug delivery carrier. In: Yarema KJ, editor. Handbook of Carbohydrate Engineering. Boca Raton, FL: CRC Press; 2005:799-816.
27. Clark AH, Ross-Murphy SB. Structural and mechanical properties of biopolymer gels. Adv Polym Sci. 1987;83:57-192.
28. Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO, Novikov LN. Alginate hydrogel and matrigel as potential cell carriers for neurotransplantation. J Biomed Mater Res A. 2006;77(2):242-252.
29. Tan WH, Takeuchi S. Monodisperse alginate hydrogel microbeads for cell encapsulation. Adv Mater. 2007;19:2696-2701.
30. Knill CJ, Kennedy JF, Mistry J, etal. Alginate fibres modified with unhydrolysed and hydrolysed chitosans for wound dressings. Carbohydr Polym. 2004;55:65-76.
31. West TP, Preece JE. Bulk alginate encapsulation of Hibiscus moscheutos nodal segments. Plant Cell Tissue Organ Cult. 2009;97:345-351.
32. Srivastava R, McShane MJ. Application of self-assembled ultra-thin film coatings to stabilize macromolecule encapsulation in alginate microspheres. J Microencapsul. 2005;22(4):397-411.
33. Ribeiro CC, Barrias CC, Barbosa MA. Calcium phosphate-alginate microspheres as enzyme delivery matrices. Biomaterials. 2004;25(18): 4363-4373.
34. Zhu H, Srivastava R, Brown JQ, McShane MJ. Combined physical and chemical immobilization of glucose oxidase in alginate microspheres improves stability of encapsulation and activity. Bioconjug Chem. 2005;16(6):1451-1458.
35. Joshi A, Keerthiprasad R, Jayant RD, Srivastava R. Nano-in-micro alginate based hybrid particles. Carbohydr Polym. 2010;81:790-798.
36. Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm. 2008;68(3):513-525.
37. Hu Y, Hu N. pH-dependent behaviors of electroactive myoglobin loaded into layer-by-layer films assembled with alginate and hydroxyethyl cellulose ethoxylate. J Phys Chem B. 2008;112(31):9523-9531.
38. Chan E-S, Lim T-K, Ravindra P, Mansa RF, Islam A. The effect of low air-to-liquid mass flow rate ratios on the size, size distribution and shape of calcium alginate particles produced using the atomization method. J Food Eng. 2012;108:297-303.
39. Liang HF, Chen SC, Chen MC, Lee PW, Chen CT, Sung HW. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Bioconjug Chem. 2006;17(2):291-299.
40. Guo H, Lai Q, Wang W, etal. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy. Int J Pharm. 2013;451(1-2):1-11.
41. Iancu C, Mocan L, Bele C, etal. Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin. Int J Nanomedicine. 2011;6:129-141.
42. Liao YT, Wu KC, Yu J. Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy. J Biomed Mater Res B Appl Biomater. 2014;102(2): 293-302.
43. Arosio D, Manzoni L, Araldi EM, Caprini A, Monferini E, Scolastico C. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging. Bioconjug Chem. 2009;20(8):1611-1617.
44. Chang RHY, Jang J, Wu KC-W. Cellulase immobilized mesoporous silica nanocatalysts for efficient cellulose-to-glucose conversion. Green Chem. 2011;13:2844-2850.
45. Herrero EP, Martín Del Valle EM, Galán MA. Development of a new technology for the production of microcapsules based in atomization processes. Chem Eng J. 2006;117:137-142.
46. Xu SW, Jiang ZY, Lu Y, Wu H, Yuan WK. Preparation and catalytic properties of novel alginate-silica-dehydrogenase hybrid biocomposite beads. Ind Eng Chem Res. 2006;45:511-517.
47. Morgan AW, Roskov KE, Lin-Gibson S, Kaplan DL, Becker ML, Simon CG Jr. Characterization and optimization of RGD-containing silk blends to support osteoblastic differentiation. Biomaterials. 2008;29(16):2556-2563.
48. Choi KY, Yoon HY, Kim JH, etal. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano. 2011;5(11): 8591-8599.
49. Brandhonneur N, Chevanne F, Vié V, etal. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. Eur J Pharm Sci. 2009;36(4-5):474-485.
50. Shimoda A, Sawada S, Akiyoshi K. Cell specific peptide-conjugated polysaccharide nanogels for protein delivery. Macromol Biosci. 2011;11(7):882-888.
51. Rosenholm JM, Meinander A, Peuhu E, etal. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano. 2009 27;3(1): 197-206.
52. Tedja R, Lim M, Amal R, Marquis C. Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano. 2012;6(5): 4083-4093.